Multi-Modal Synergistic 99mTc-TRODAT-1 SPECT and MRI for Evaluation of the Efficacy of Hyperbaric Oxygen Therapy in CO-Induced Delayed Parkinsonian and Non-Parkinsonian Syndromes | Canada Hyperbarics Skip to main content
Study Antioxidants (Basel) 2022

Multi-Modal Synergistic 99mTc-TRODAT-1 SPECT and MRI for Evaluation of the Efficacy of Hyperbaric Oxygen Therapy in CO-Induced Delayed Parkinsonian and Non-Parkinsonian Syndromes

Yeh S, Chiu C, Kao H, Lin C, Lai Y, Huang W — Antioxidants (Basel), 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated 21 patients who developed delayed neurological issues after carbon monoxide poisoning, using brain scans before and after hyperbaric oxygen therapy to assess changes in brain function.

What They Found

Over 70% (15 out of 21) of patients with delayed neurological issues showed damage in a specific brain area called the globus pallidus on MRI scans. These patients also had significantly lower levels of a brain chemical marker (dopamine transporter or DAT) (p < 0.005). After HBOT, the levels of this brain chemical marker increased by about 11% in both sides of the brain for patients with Parkinsonian symptoms, with the left side showing a significantly better recovery (p < 0.005).

What This Means for Canadian Patients

For Canadian patients experiencing delayed neurological problems, including Parkinsonian symptoms, after carbon monoxide poisoning, this study suggests that HBOT may help improve brain chemical levels related to movement. The use of specific brain scans could assist doctors in evaluating the risk of Parkinsonism and tracking the effects of HBOT in these patients.

Canadian Relevance

Although this study was not conducted in Canada, it covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

A limitation of this study is its relatively small sample size of 21 patients, which may affect the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Study
Category Neurological
Source Pubmed
PubMed ID 36421475
Year Published 2022
Journal Antioxidants (Basel)

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.